|By Marketwired .||
|April 28, 2014 09:55 AM EDT||
TORONTO, ONTARIO -- (Marketwired) -- 04/28/14 -- Vida Cannabis Corp. ("Vida Cannabis") is pleased to announce the appointment of Christopher Hansen to its board of directors.
With more than 25 years of experience, primarily in Latin America and Africa, Christopher Hansen is a senior financial, micro and small and medium enterprise expert. He is currently Director of Latin American Business Development for GIC Group in the areas of agribusiness, food security and food safety. In addition, Mr. Hansen is Visiting Scientist with the Global Seed Program of Iowa State University's Seed Science Center, assisting small farmers and seed companies in rural areas of Latin America to increase productivity and incomes through the use of certified seed and enhance food security in the region.
From 2006 to 2012, Mr. Hansen led initiatives in Latin America for the Inter-American Institute for Cooperation on Agriculture (IICA), including as country representative to Colombia, Deputy Director, Associate Deputy Director, US Representative and Director of Strategic Partnerships on projects in such areas as energy efficiency, sustainable forestry management, cacao rehabilitation, women's entrepreneurship, irrigation, tourism, agribusiness and aquaculture. He was Chief Financial Officer and Director Corporate Development for Sea Farms International, a large shrimp farming operation in Honduras and Venezuela, and Chief of Party for the USAID Colombian Enterprise Development Program.
Previously, Chris Hansen worked as Deputy Director and Manager, Financial Services for FUNDES, the Foundation for Sustainable Development in Latin America, in Costa Rica. From 1982-1996 he worked with the International Finance Corporation (private sector arm of the World Bank), as a Senior Investment Officer responsible for agribusiness investments in Latin American and Caribbean Region.
Christopher Hansen earned an MBA in International Finance from the University of California-Berkeley after receiving a B.A. in Political Science there. He previously studied pre-law at Willamette University in Oregon. Chris is a native English speaker fluent in Spanish.
Vida Cannabis CEO Greg Wilson stated: "As Vida Cannabis continues to analyze the global landscape for countries where clearly defined regulatory environments are favorable to establishing low-risk/high-reward marijuana production operations, such as those currently being implemented in Canada, Chris Hansen's financial expertise and global business experience working with governments and international agencies focused on agricultural development projects will be extremely beneficial for Vida Cannabis.
"Vida Cannabis is intent on staking a leadership position as the premium producer of marijuana as the world rapidly evolves from an environment of prohibition to one where medical and in some cases recreational markets are now able to flourish. I look forward to working with Chris and welcome him to the Vida board."
About Vida Cannabis Corp.
Vida Cannabis Corp. ("Vida Cannabis") is focused on developing a dominant production footprint in the rapidly developing global marketplace for the legal use of medicinal and recreational marijuana.
Initial operations are focused on the Canadian market where Health Canada has established national guidelines enabling best-in-class producers to acquire commercial production licenses under the Marihuana for Medical Purposes Regulations.
Via its wholly owned subsidiary, Vida Cannabis (Canada) Ltd., Vida Cannabis purchased a 315,000-square-foot production facility in the town of Stellarton, NS and secured a 50-year irrevocable approval unanimously from the local municipality to operate a medical marijuana production plant at the facility.
The highly secure facility boasts a fully engineered concrete floor, 18-foot-high concrete walls and a steel roof making it an ideal location for the construction of a customized, state-of-the-art modern medical marijuana production plant.
Vida Cannabis is working with one of the most talented cannabis consulting teams in the world, Quantum 9 Inc., which has extensive resources in the United States, Canada and Europe, to establish an optimized end-to-end production plan to help position Vida Cannabis with the largest, most advanced medical marijuana facility in Canada.
Vida Cannabis continues to evaluate additional potential markets as regulatory bodies around the world pass legislation enabling the production and distribution of medicinal or recreational marijuana.
On behalf of the board,
Greg Wilson - Chairman & CEO
Vida Cannabis Corp.
This announcement does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell, a solicitation to purchase, or advice on investments in any securities of Vida Cannabis Corp. ("Vida Cannabis"). Offers and solicitations shall be expressly identified as such and made in compliance with applicable securities laws. This announcement is for information purposes only. It should not be relied upon as a basis for investment decisions. You should consult with your own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of any investments you are considering. Whilst the information provided here is believed to be reliable, it cannot be guaranteed. It may contain forward-looking statements made by or on behalf of Vida Cannabis about its business or financial objectives, position, strategies or expectations. Such forward-looking statements may be identified by words such as, or similar to, "intends," "anticipates," "believes," "expects" and "hopes" and includes, without limitation, the development of production facilities, approval from regulatory authorities and the ability for Vida Cannabis to obtain adequate financing to meet its business objectives. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. The statements in this announcement do not guarantee future performance. Vida Cannabis does not undertake any obligation to update any information provided in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned subsidiary of Vida Cannabis, must obtain approval from Health Canada in order to operate as a licensed commercial producer under the Marihuana for Medical Purposes Regulations. Vida Cannabis makes no representations or warranties that it will receive Health Canada approval.
Oct. 22, 2016 11:30 AM EDT Reads: 455
Oct. 22, 2016 11:30 AM EDT Reads: 1,403
Oct. 22, 2016 11:00 AM EDT Reads: 8,211
Oct. 22, 2016 10:45 AM EDT Reads: 1,143
Oct. 22, 2016 10:45 AM EDT Reads: 3,617
Oct. 22, 2016 10:30 AM EDT Reads: 3,623
Oct. 22, 2016 10:15 AM EDT Reads: 518
Oct. 22, 2016 09:30 AM EDT Reads: 1,256
Oct. 22, 2016 09:15 AM EDT Reads: 706
Oct. 22, 2016 09:15 AM EDT Reads: 1,411
Oct. 22, 2016 08:45 AM EDT Reads: 2,039
Oct. 22, 2016 08:30 AM EDT Reads: 725
Oct. 22, 2016 08:30 AM EDT Reads: 931
Oct. 22, 2016 08:15 AM EDT Reads: 3,757
Oct. 22, 2016 08:15 AM EDT Reads: 2,096